https://pharmoniq.com/news/fda-approves-first-mct8-deficiency-treatment PharmoniQ en 2026-10-01T14:10:49.291Z FDA Approves First-Ever Treatment for MCT8 Deficiency FDA approval, rare disease, MCT8 deficiency, orphan drug, thyroid disorder https://pharmoniq.com/news/drug-repurposing-market-29-billion-pharma-strategy-shift PharmoniQ en 2026-10-01T08:47:02.899Z Drug Repurposing Market Hits $29.4B as Industry Seeks Cost Relief drug repurposing, pharma R&D, pharmaceutical innovation, drug development costs, clinical trials https://pharmoniq.com/news/fda-class-i-recall-thyroid-medication-hormone-overdose PharmoniQ en 2026-09-30T14:10:49.874Z FDA Elevates Thyroid Medication Recall to Class I Over Overdose Risk FDA recall, thyroid medication, Class I recall, hormone overdose, drug safety